Developer docs
API playgroundTry for free, no card

Search company profiles

Canify

Full company profile

uuid000a95f

Namestring
Canify
Legal namestring
Canify AG
Websiteurl
canify.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Canify AG is a German licensed pharmaceutical company focused on the import, EU-GMP certified processing, packaging, and distribution of medical cannabis to pharmacies and pharmaceutical wholesalers across Europe. The company was formed in June 2022 through the merger of Bavaria Weed GmbH (Herrsching, Germany) and Canify AS (Denmark), and operates from a headquarters in Herrsching am Ammersee with production at a former NATO bunker facility in Leipheim that is qualified to EU-GMP and GDP standards and can store up to two tons of cannabis. Its product portfolio spans dried cannabis flowers across tiers (Canify Basic, Pure, Choice, Craft), cannabis extracts co-developed with Somai, exclusive Tikun Olam Europe cultivars distributed via Dopiopharm, a sublingual cannabinoid spray (Xatepa), and the Canify Sun line sourced from Uruguay — all underpinned by a multi-jurisdictional supplier base in Lesotho, Portugal, Colombia, Greece, and Uruguay.

Revenue is generated primarily through unit-priced B2B sales of cannabis flowers and extracts to validated German pharmacies (priced at €2.65–€9.95 per gram) and European pharmaceutical wholesalers, supplemented by contract manufacturing and market access services for third-party cannabis producers covering supplier qualification, laboratory analysis, GMP processing, batch release, warehousing, and distribution. Distribution is executed through a direct pharmacy sales infrastructure (hotline, Fachkreis portal, DocCheck validation) supported by Phoenix BTM for BtM-compliant logistics, with the CATHAROS digital marketplace — launching in 2026 in partnership with IhreApotheken.de — adding a patient-facing channel connected to up to 7,500 pharmacies. As of 2025, the company reported €15.5M in revenue for the first nine months (up 250% year-over-year) with over 7 tons processed, and is pursuing pre-IPO equity financing alongside a merger with MG Health to integrate cultivation upstream.

Short descriptiontext

Canify AG is a German licensed pharmaceutical company that imports, EU-GMP processes, and distributes medical cannabis to German pharmacies and European pharmaceutical wholesalers across multiple product tiers, with a digital marketplace expansion in 2026.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHerrsching Am Ammersee, Germany
HQ citystring
Herrsching Am Ammersee
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis pharmaceuticals, cannabis contract manufacturing, EU-GMP cannabis production, cannabis wholesale distribution, medical cannabis marketplace
Industry4 codes
PRIMARYCRANAGAG
Medical Cannabis Delivery & Online Ordering
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
SECONDARYCRAOAIAF
Cannabis Wholesale Distribution (Flower, Extracts, Edibles)
Consumer Products & Retail/Wholesale, Distribution & Category Management/Alcohol, Tobacco & Cannabis Wholesale Distribution
SECONDARYCRANAGAF
Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
SECONDARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Medical Cannabis Pharmaceuticals
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Cannabis Product Sales
TypeOne Time License
Description

Sale of dried cannabis flowers and cannabis extracts to pharmacies and wholesalers across Europe. Products include various THC/CBD ratios and cultivars sourced from international cultivators.

canify.com
2Contract Manufacturing Services (CMO)
TypeProfessional Services
Description

Full-service solutions for third-party medical cannabis products including supplier qualification, laboratory analysis, stability testing, import, GMP processing, batch release, warehousing and distribution.

canify.com
3Market Access Platform Services
TypeProfessional Services
Description

Consulting services for market access including EU GDP license acquisition, EU-GACP certification, digital quality management systems, and product sourcing.

canify.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details5 tiers
1Canify Basic - Standard cannabis products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Entry-level products with standard pricing for cannabis flowers from €2.65/g for 30g units up to €8.90/g for 10g units depending on cultivar.

2Canify Pure - Premium processed products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Mid-tier products with enhanced processing and quality standards.

3Canify Choice - Selected cultivars
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Curated selection of specific cannabis cultivars.

4Canify Craft - Premium hand-selected flowers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Hand-selected flowers with special breeding characteristics and outstanding quality for premium segment.

5Dopiopharm Products - Tikun Olam Europe cultivars
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Exclusive cultivars from Tikun Olam Europe including Tikun Erez, Tikun Midnight, Tikun GNC, Tikun Noga, Tikun OZ, Tikun CAP J.

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1Canify Pure
Description

Premium cannabis product line

canify.com
+8 more records
Core offering1 text field

Canify AG manufactures and distributes EU-GMP and GDP-certified medical cannabis products — dried cannabis flowers and cannabinoid extracts — to pharmacies and pharmaceutical wholesalers across Europe. In addition to its own product portfolio, the company offers contract manufacturing (CMO) and market-access services for third-party cannabis producers, covering supplier qualification, GMP processing, laboratory analysis, batch release, warehousing, and distribution from its former-NATO-bunker production facility in Leipheim, Germany.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Revenue increased 250% year-over-year to €15.5 million in first nine months of 2025
+1 more record
Product and service6 records
1Canify Pharma — Medical Cannabis Flowers & Extracts (Canify Basic / Pure / Choice / Craft / Canify Sun / Ghostdrops)
CategoryMedical cannabis pharmaceuticals
Description

EU-GMP and GDP-certified medical cannabis flowers and extracts sold to licensed German pharmacies and European pharmaceutical wholesalers. Products span multiple THC/CBD ratios and cultivars sourced from international cultivation partners (MG Health, Somai, Clever Leaves, Tikun Olam Europe, Fotmer).

2Xatepa Sublingualspray
CategoryMedical cannabis pharmaceuticals
Description

Rezepturarzneimittel cannabinoid-based prescription medicine in sublingual spray form, using an innovative formulation technology for faster active-ingredient absorption versus other delivery methods. Marketed to pharmacies dispensing medical cannabis prescriptions.

3Somai Canify Cannabis Extracts
CategoryMedical cannabis pharmaceuticals
Description

Differentiated cannabis extract line developed with SOMAI Pharmaceuticals featuring an additional purification step, sold in various THC/CBD ratios to German pharmacies under the "Somai Canify Cannabisextrakt" brand.

4Dopiopharm Tikun Olam Europe Cultivars
CategoryMedical cannabis pharmaceuticals
Description

Distribution of Tikun Olam Europe's medical cannabis cultivars to the German market via Dopiopharm GmbH partnership, including Tikun Erez, Midnight, GNC, Noga, OZ, and CAP J varieties.

5CATHAROS Digital Marketplace
CategoryDigital pharmacy marketplace
Description

Pharmacy-centric digital marketplace connecting medical cannabis patients with a network of up to 7,500 participating German pharmacies, ensuring legally compliant prescription fulfilment and guaranteed product availability. Built in partnership with IhreApotheken.de using their digital infrastructure.

6Canify Services — Contract Manufacturing (CMO) & Market Access Platform
CategoryPharmaceutical contract manufacturing and market access services
Description

Full-service contract manufacturing and EU Market Access Platform for third-party medical cannabis producers, spanning supplier qualification, GMP processing, batch release, BtM/GDP storage, contract logistics, and distribution. Customers include international cannabis cultivators needing a compliant route into the German/European market.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-14
Description

Launch of CATHAROS digital marketplace for medical cannabis in Germany, scheduled for 2026. The platform connects patients directly with pharmacies, leveraging iA.de's existing digital infrastructure of up to 7,500 pharmacies. Both companies will create a pharmacy-centric solution for legally compliant prescriptions.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-12
Description

Merger announcement to form an international leading provider for medical cannabis. The combined entity will integrate cultivation, EU-GMP certified production through to patients. MG Health supplies cannabis flowers from Lesotho including cultivars Exodus Cheese, Durban Sky, and others.

3Dopiopharm GmbH
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-03-10
Description

Partnership to bring Tikun Olam Europe cultivars to the German market. Tikun Olam is a long-established medical cannabis company with roots in Israel. Products include Tikun Erez, Tikun Midnight, Tikun GNC, Tikun Noga, Tikun OZ, and Tikun CAP J cultivars.

canify.com
4Alveon GmbH
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-25
Description

Joint venture to develop and globally market an innovative medical device for vaporizing medical cannabis extracts. The partnership combines Canify's cannabis expertise with Alveon's medical technology capabilities.

canify.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-08-22
Description

New supplier of cannabis flowers from Lesotho. MG Health fulfills Canify's quality requirements and provides ecological and social responsibility through their supply chain engagement. Portfolio includes well-known cultivars returning to the German market.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-08-01
Description

Collaboration with Portuguese pharmaceutical company Somai to launch next-generation cannabis extracts on the German market. Extracts feature an additional purification step distinguishing them from other cannabis extracts.

7SOMAI Pharmaceuticals
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-12-19
Description

Partnership for joint marketing of differentiated cannabinoid-based product line in Germany. SOMAI produces cannabis extracts with an additional purification step in their production process. Products sold as 'Somai Canify Cannabisextrakt' in various THC/CBD ratios.

canify.com
8Phoenix BTM
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Contract logistics and delivery partner for BTM (narcotics) and GDP storage, handling pharmacy distribution in Germany.

canify.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German medical cannabis producer and distributor with EU-GMP production and direct pharmacy/wholesale relationships. Most direct domestic comparable to Canify given its similar positioning in the German pharmacy-channel.

TypeDirect peer
Description

Germany's largest independent medical-cannabis B2B platform, distributing to pharmacies and offering its own product lines. Highly comparable as a German distributor/producer using EU-GMP product flows.

TypeDirect peer
Description

Berlin-based medical cannabis company distributing EU-GMP cannabis flowers and extracts to German pharmacies, with proprietary strains sourced internationally. Direct competitor in the German wholesale channel.

TypeDirect peer
Description

Berlin-headquartered medical cannabis company active in cultivation, manufacturing, and distribution in Germany. Comparable vertical scope and German-market focus.

TypeDirect peer
Description

Cologne-based medical cannabis wholesaler supplying German pharmacies with EU-GMP cannabis flowers and extracts from international cultivators. Direct overlap in pharmacy-channel distribution model.

6Tilray Brands
TypeBroad incumbent
Description

Global cannabis major with established EU presence and medical cannabis brands in Germany. Broad incumbent competing in the same end-market with deeper capital and broader product range.

TypeBroad incumbent
Description

Canadian-headquartered global cannabis producer with European medical cannabis operations including Germany. Larger incumbent competing for EU-GMP-certified product share.

TypeBroad incumbent
Description

Global cannabis major with medical cannabis offerings across Europe. Broad incumbent with scale advantages Canify must compete against for pharmacy and wholesaler mindshare.

TypeEmerging player
Description

Colombian-based EU-GMP-certified cannabis cultivator supplying Canify and other European distributors. Both supplier and partial peer given its cultivation-scale and EU-GMP footprint.

TypeBroad incumbent
Description

Global cannabis operator with international medical and consumer offerings, including European distribution. Comparable as a peer in medical-cannabis cross-border distribution and GMP manufacturing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Canify

Medical Cannabis Pharmaceuticalscanify.com

Canify AG is a German licensed pharmaceutical company that imports, EU-GMP processes, and distributes medical cannabis to German pharmacies and European pharmaceutical wholesalers across multiple product tiers, with a digital marketplace expansion in 2026.

What Canify does

Canify AG is a German licensed pharmaceutical company focused on the import, EU-GMP certified processing, packaging, and distribution of medical cannabis to pharmacies and pharmaceutical wholesalers across Europe. The company was formed in June 2022 through the merger of Bavaria Weed GmbH (Herrsching, Germany) and Canify AS (Denmark), and operates from a headquarters in Herrsching am Ammersee with production at a former NATO bunker facility in Leipheim that is qualified to EU-GMP and GDP standards and can store up to two tons of cannabis. Its product portfolio spans dried cannabis flowers across tiers (Canify Basic, Pure, Choice, Craft), cannabis extracts co-developed with Somai, exclusive Tikun Olam Europe cultivars distributed via Dopiopharm, a sublingual cannabinoid spray (Xatepa), and the Canify Sun line sourced from Uruguay — all underpinned by a multi-jurisdictional supplier base in Lesotho, Portugal, Colombia, Greece, and Uruguay.

Revenue is generated primarily through unit-priced B2B sales of cannabis flowers and extracts to validated German pharmacies (priced at €2.65–€9.95 per gram) and European pharmaceutical wholesalers, supplemented by contract manufacturing and market access services for third-party cannabis producers covering supplier qualification, laboratory analysis, GMP processing, batch release, warehousing, and distribution. Distribution is executed through a direct pharmacy sales infrastructure (hotline, Fachkreis portal, DocCheck validation) supported by Phoenix BTM for BtM-compliant logistics, with the CATHAROS digital marketplace — launching in 2026 in partnership with IhreApotheken.de — adding a patient-facing channel connected to up to 7,500 pharmacies. As of 2025, the company reported €15.5M in revenue for the first nine months (up 250% year-over-year) with over 7 tons processed, and is pursuing pre-IPO equity financing alongside a merger with MG Health to integrate cultivation upstream.

Canify firmographics

Firmographics
Name
Canify
Legal name
Canify AG
Website
https://canify.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Canify AG is a German licensed pharmaceutical company that imports, EU-GMP processes, and distributes medical cannabis to German pharmacies and European pharmaceutical wholesalers across multiple product tiers, with a digital marketplace expansion in 2026.
Ownership category
akta.pro rank

Canify industry classification

Industry
Product category
Medical Cannabis Pharmaceuticals
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRANAGAG
Medical Cannabis Delivery & Online Ordering
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
SECONDARYCRAOAIAF
Cannabis Wholesale Distribution (Flower, Extracts, Edibles)
Consumer Products & Retail/Wholesale, Distribution & Category Management/Alcohol, Tobacco & Cannabis Wholesale Distribution
SECONDARYCRANAGAF
Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
SECONDARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Medical cannabis pharmaceuticals
  • Cannabis contract manufacturing
  • EU-GMP cannabis production
  • Cannabis wholesale distribution
  • Medical cannabis marketplace

Where Canify is headquartered

Location

Headquarters

HQ city
Herrsching Am Ammersee
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Canify business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Cannabis Product Sales: Sale of dried cannabis flowers and cannabis extracts to pharmacies and wholesalers across Europe. Products include various THC/CBD ratios and cultivars sourced from international cultivators.
  2. Contract Manufacturing Services (CMO): Full-service solutions for third-party medical cannabis products including supplier qualification, laboratory analysis, stability testing, import, GMP processing, batch release, warehousing and distribution.
  3. Market Access Platform Services: Consulting services for market access including EU GDP license acquisition, EU-GACP certification, digital quality management systems, and product sourcing.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCanify Basic - Standard cannabis products
Unit PricingPay-as-you-goCanify Pure - Premium processed products
Unit PricingPay-as-you-goCanify Choice - Selected cultivars
Unit PricingPay-as-you-goCanify Craft - Premium hand-selected flowers
Unit PricingPay-as-you-goDopiopharm Products - Tikun Olam Europe cultivars

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Canify product offering

Product offering

Core offering

Canify AG manufactures and distributes EU-GMP and GDP-certified medical cannabis products — dried cannabis flowers and cannabinoid extracts — to pharmacies and pharmaceutical wholesalers across Europe. In addition to its own product portfolio, the company offers contract manufacturing (CMO) and market-access services for third-party cannabis producers, covering supplier qualification, GMP processing, laboratory analysis, batch release, warehousing, and distribution from its former-NATO-bunker production facility in Leipheim, Germany.

Differentiator

Problem solved

Functional benefit

Brands

  • Canify Pure: Premium cannabis product line
  • Canify Basic
  • Canify Choice
  • Canify Craft
  • Xatepa
  • Canify Sun
  • Somai Canify Cannabis Extracts
  • Ghostdrops
  • CATHAROS

Products and services

  • Canify Pharma — Medical Cannabis Flowers & Extracts (Canify Basic / Pure / Choice / Craft / Canify Sun / Ghostdrops) EU-GMP and GDP-certified medical cannabis flowers and extracts sold to licensed German pharmacies and European pharmaceutical wholesalers. Products span multiple THC/CBD ratios and cultivars sourced from international cultivation partners (MG Health, Somai, Clever Leaves, Tikun Olam Europe, Fotmer).
  • Xatepa Sublingualspray Rezepturarzneimittel cannabinoid-based prescription medicine in sublingual spray form, using an innovative formulation technology for faster active-ingredient absorption versus other delivery methods. Marketed to pharmacies dispensing medical cannabis prescriptions.
  • Somai Canify Cannabis Extracts Differentiated cannabis extract line developed with SOMAI Pharmaceuticals featuring an additional purification step, sold in various THC/CBD ratios to German pharmacies under the "Somai Canify Cannabisextrakt" brand.
  • Dopiopharm Tikun Olam Europe Cultivars Distribution of Tikun Olam Europe's medical cannabis cultivars to the German market via Dopiopharm GmbH partnership, including Tikun Erez, Midnight, GNC, Noga, OZ, and CAP J varieties.
  • CATHAROS Digital Marketplace Pharmacy-centric digital marketplace connecting medical cannabis patients with a network of up to 7,500 participating German pharmacies, ensuring legally compliant prescription fulfilment and guaranteed product availability. Built in partnership with IhreApotheken.de using their digital infrastructure.
  • Canify Services — Contract Manufacturing (CMO) & Market Access Platform Full-service contract manufacturing and EU Market Access Platform for third-party medical cannabis producers, spanning supplier qualification, GMP processing, batch release, BtM/GDP storage, contract logistics, and distribution. Customers include international cannabis cultivators needing a compliant route into the German/European market.

Quantifiable outcome

  • Revenue increased 250% year-over-year to €15.5 million in first nine months of 2025
  • +1 more outcomes

Companies that use Canify

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Canify technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Canify partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship and core.

  • IhreApotheken.de KGaAflagshipStrategic or Co-development Partner · 14 April 2026Launch of CATHAROS digital marketplace for medical cannabis in Germany, scheduled for 2026. The platform connects patients directly with pharmacies, leveraging iA.de's existing digital infrastructure of up to 7,500 pharmacies. Both companies will create a pharmacy-centric solution for legally compliant prescriptions.
  • MG Health (Lesotho)coreTechnology or Integration · 12 March 2026Merger announcement to form an international leading provider for medical cannabis. The combined entity will integrate cultivation, EU-GMP certified production through to patients. MG Health supplies cannabis flowers from Lesotho including cultivars Exodus Cheese, Durban Sky, and others.
  • Dopiopharm GmbHcoreTechnology or Integration · 10 March 2025Partnership to bring Tikun Olam Europe cultivars to the German market. Tikun Olam is a long-established medical cannabis company with roots in Israel. Products include Tikun Erez, Tikun Midnight, Tikun GNC, Tikun Noga, Tikun OZ, and Tikun CAP J cultivars.
  • Alveon GmbHcoreStrategic or Co-development Partner · 25 November 2024Joint venture to develop and globally market an innovative medical device for vaporizing medical cannabis extracts. The partnership combines Canify's cannabis expertise with Alveon's medical technology capabilities.
  • MG HealthcoreTechnology or Integration · 22 August 2024New supplier of cannabis flowers from Lesotho. MG Health fulfills Canify's quality requirements and provides ecological and social responsibility through their supply chain engagement. Portfolio includes well-known cultivars returning to the German market.
  • SomaicoreTechnology or Integration · 1 August 2024Collaboration with Portuguese pharmaceutical company Somai to launch next-generation cannabis extracts on the German market. Extracts feature an additional purification step distinguishing them from other cannabis extracts.
  • SOMAI PharmaceuticalscoreTechnology or Integration · 19 December 2023Partnership for joint marketing of differentiated cannabinoid-based product line in Germany. SOMAI produces cannabis extracts with an additional purification step in their production process. Products sold as 'Somai Canify Cannabisextrakt' in various THC/CBD ratios.
  • Phoenix BTMcoreChannel Partner/ Reseller/ DistributorContract logistics and delivery partner for BTM (narcotics) and GDP storage, handling pharmacy distribution in Germany.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Canify competitors and assessment

Company assessment

Direct peers

  • Demecan: German medical cannabis producer and distributor with EU-GMP production and direct pharmacy/wholesale relationships. Most direct domestic comparable to Canify given its similar positioning in the German pharmacy-channel.
  • Cansativa: Germany's largest independent medical-cannabis B2B platform, distributing to pharmacies and offering its own product lines. Highly comparable as a German distributor/producer using EU-GMP product flows.
  • Cantourage: Berlin-based medical cannabis company distributing EU-GMP cannabis flowers and extracts to German pharmacies, with proprietary strains sourced internationally. Direct competitor in the German wholesale channel.
  • Sanity Group: Berlin-headquartered medical cannabis company active in cultivation, manufacturing, and distribution in Germany. Comparable vertical scope and German-market focus.
  • Cannamedical Pharma: Cologne-based medical cannabis wholesaler supplying German pharmacies with EU-GMP cannabis flowers and extracts from international cultivators. Direct overlap in pharmacy-channel distribution model.

Broad incumbents

  • Tilray Brands: Global cannabis major with established EU presence and medical cannabis brands in Germany. Broad incumbent competing in the same end-market with deeper capital and broader product range.
  • Aurora Cannabis: Canadian-headquartered global cannabis producer with European medical cannabis operations including Germany. Larger incumbent competing for EU-GMP-certified product share.
  • Canopy Growth: Global cannabis major with medical cannabis offerings across Europe. Broad incumbent with scale advantages Canify must compete against for pharmacy and wholesaler mindshare.
  • Cronos Group: Global cannabis operator with international medical and consumer offerings, including European distribution. Comparable as a peer in medical-cannabis cross-border distribution and GMP manufacturing.

Emerging players

  • Clever Leaves: Colombian-based EU-GMP-certified cannabis cultivator supplying Canify and other European distributors. Both supplier and partial peer given its cultivation-scale and EU-GMP footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Canify social profiles

Digital presence

Canify financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Canify leadership team

Management profile

Number of profiles

Profiles12 records

Canify subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Canify funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Canify M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canify

What does Canify do?

Canify AG manufactures and distributes EU-GMP and GDP-certified medical cannabis products — dried cannabis flowers and cannabinoid extracts — to pharmacies and pharmaceutical wholesalers across Europe. In addition to its own product portfolio, the company offers contract manufacturing (CMO) and market-access services for third-party cannabis producers, covering supplier qualification, GMP processing, laboratory analysis, batch release, warehousing, and distribution from its former-NATO-bunker production facility in Leipheim, Germany.

Is Canify a public or private company?

Canify is a private company. It is classified as venture growth investor backed and is currently operating.

When was Canify founded?

Canify was founded in 2022. It employs 11 to 50 people.

Where is Canify based?

Canify is headquartered in Herrsching Am Ammersee, Germany, in the Europe region.

How does Canify make money?

Three revenue lines are on record. Medical Cannabis Product Sales are the primary driver. The others are contract Manufacturing Services (CMO) and market Access Platform Services.

Who are Canify's main competitors?

Direct peers on record are Demecan, Cansativa, Cantourage, Sanity Group and Cannamedical Pharma. Broad incumbents are Tilray Brands, Aurora Cannabis, Canopy Growth and Cronos Group. Clever Leaves is listed as an emerging player.

Does Canify have an API?

No public API is recorded for Canify.

What industry is Canify in?

Canify's product category is Medical Cannabis Pharmaceuticals. Its primary akta.pro industry code is CRANAGAG, Medical Cannabis Delivery & Online Ordering, with a secondary code of CRAOAIAF, Cannabis Wholesale Distribution (Flower, Extracts, Edibles). Its NAICS code is 325411 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals